[go: up one dir, main page]

DK2934189T3 - Humane mælkeoligosaccharider til reduktion af stress-symptomer - Google Patents

Humane mælkeoligosaccharider til reduktion af stress-symptomer Download PDF

Info

Publication number
DK2934189T3
DK2934189T3 DK13818905T DK13818905T DK2934189T3 DK 2934189 T3 DK2934189 T3 DK 2934189T3 DK 13818905 T DK13818905 T DK 13818905T DK 13818905 T DK13818905 T DK 13818905T DK 2934189 T3 DK2934189 T3 DK 2934189T3
Authority
DK
Denmark
Prior art keywords
human milk
reducing stress
milk oligosaccharides
stress symptoms
symptoms
Prior art date
Application number
DK13818905T
Other languages
English (en)
Inventor
Jomay Chow
Matthew Panasevich
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49943540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2934189(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK2934189T3 publication Critical patent/DK2934189T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK13818905T 2012-12-18 2013-12-18 Humane mælkeoligosaccharider til reduktion af stress-symptomer DK2934189T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261738491P 2012-12-18 2012-12-18
PCT/US2013/076026 WO2014100126A1 (en) 2012-12-18 2013-12-18 Human milk oligosaccharides to ameliorate symptoms of stress

Publications (1)

Publication Number Publication Date
DK2934189T3 true DK2934189T3 (da) 2019-11-25

Family

ID=49943540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13818905T DK2934189T3 (da) 2012-12-18 2013-12-18 Humane mælkeoligosaccharider til reduktion af stress-symptomer

Country Status (14)

Country Link
US (1) US10779550B2 (da)
EP (1) EP2934189B1 (da)
CN (1) CN104822279B (da)
BR (1) BR112015014420A2 (da)
CA (1) CA2893217C (da)
DK (1) DK2934189T3 (da)
ES (1) ES2763958T3 (da)
IL (1) IL239107A0 (da)
MX (1) MX391839B (da)
MY (1) MY187609A (da)
PH (1) PH12015501309A1 (da)
SG (1) SG11201504579QA (da)
TW (1) TW201438719A (da)
WO (1) WO2014100126A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2880993A1 (en) * 2013-12-04 2015-06-10 Abbott Laboratories Method of achieving memory and learning improvement by the administration of sialic acid
WO2016014502A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder with specific antioxidants
CN106659218A (zh) * 2014-07-21 2017-05-10 雅培制药有限公司 具有人乳寡糖的营养物递送系统
EP3171743A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutritional powder pods comprising dry blended carbohydrates
WO2016014497A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder pods containing nutritional powders with volume flowability properties
EP3171745A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutritional powder pods and related methods
US20170181463A1 (en) * 2014-07-21 2017-06-29 Abbott Laboratories Nutrient delivery system comprising nutritional powder comprising phospholipids to improve wettability
EP3171716A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutritional powder pod with extruded nutritional powder
CN116650541A (zh) * 2014-10-29 2023-08-29 拜奥生物技术有限公司 使用罗伊氏乳杆菌在生命早期恢复微生物群生态失调
CN108348535B (zh) * 2015-10-28 2021-08-31 格礼卡姆股份公司 用于调节脑功能和行为的合成组合物和方法
US10780103B2 (en) * 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
SG11201805791RA (en) * 2016-01-13 2018-08-30 Benebiosis Co Ltd COMPOSITION FOR INCREASING EXPRESSION OF PGC-1α
WO2017215722A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic composition comprising hmo and method for modulating emotion and mood disorders
SG11201811807XA (en) 2016-07-28 2019-02-27 Fonterra Cooperative Group Ltd Dairy product and process
WO2018215960A1 (en) * 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising one or more human milk oligosaccharides (hmos)
AU2018272156B2 (en) * 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
CN111526879A (zh) * 2017-11-02 2020-08-11 格礼卡姆股份公司 用于减少或预防疲劳和/或改善注意力或专注力的一种或多种hmo
JP7327724B2 (ja) 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのｈｍｏの混合物
KR20200096771A (ko) * 2017-12-08 2020-08-13 젠와인 바이오테크놀로지 게엠바하 분무건조된 락토-n-푸코펜타오스
US11304966B2 (en) * 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
CN112384227A (zh) * 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
WO2019155043A1 (en) * 2018-02-09 2019-08-15 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
EP3546060A1 (en) * 2018-03-27 2019-10-02 DuPont Nutrition Biosciences ApS Process for spray drying fucosyllactose solutions and related product compositions
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
CN109355231A (zh) * 2018-11-28 2019-02-19 江苏微康生物科技有限公司 有机益生菌菌粉的制备方法
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
KR102241938B1 (ko) * 2020-09-14 2021-04-20 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물
EP4186512A4 (en) 2020-09-14 2024-08-14 Advanced Protein Technologies Corp. Food composition for alleviating or treating cardio-cerebrovascular disease, and pharmaceutical composition for preventing or treating cardio-cerebrovascular disease, comprising 2'-fucosyllactose
WO2022106416A1 (en) * 2020-11-23 2022-05-27 Dsm Ip Assets B.V. Edible decorative element comprising human milk oligosacchrides
WO2023237306A1 (en) * 2022-06-09 2023-12-14 Dsm Ip Assets B.V. Nutritional composition comprising gos and hmos
WO2024175626A1 (en) * 2023-02-22 2024-08-29 Beneo-Orafti S.A. Prebiotic composition
CN119344376B (zh) * 2024-12-27 2025-04-08 内蒙古伊利实业集团股份有限公司 可用于提升和/或改善个体社会行为的营养组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300236A3 (en) 1997-02-21 2003-09-29 Univ Tennessee Res Corp Knoxvi Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
DE602004006258T3 (de) 2004-08-24 2013-08-29 Nutricia N.V. Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
US8968722B2 (en) * 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
ES2804258T3 (es) * 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
MX375120B (es) * 2010-12-31 2025-03-06 Abbott Lab Oligosacáridos de leche humana para modular la inflamación.
SG191392A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
ES2572831T3 (es) * 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico

Also Published As

Publication number Publication date
PH12015501309A1 (en) 2015-08-24
BR112015014420A2 (pt) 2017-07-11
HK1217082A1 (en) 2016-12-23
EP2934189B1 (en) 2019-11-06
EP2934189A1 (en) 2015-10-28
US10779550B2 (en) 2020-09-22
IL239107A0 (en) 2015-07-30
CN104822279B (zh) 2020-09-11
ES2763958T3 (es) 2020-06-01
MY187609A (en) 2021-10-04
CA2893217A1 (en) 2014-06-26
US20150320778A1 (en) 2015-11-12
CN104822279A (zh) 2015-08-05
TW201438719A (zh) 2014-10-16
MX2015007933A (es) 2015-10-09
WO2014100126A1 (en) 2014-06-26
CA2893217C (en) 2017-11-28
MX391839B (es) 2025-03-19
SG11201504579QA (en) 2015-07-30

Similar Documents

Publication Publication Date Title
DK2934189T3 (da) Humane mælkeoligosaccharider til reduktion af stress-symptomer
IL275998B (en) Medical system
DK3170520T3 (da) Motoriseret udskylningssystem
BR112015006198A2 (pt) conjunto de cadeira
PT2819623T (pt) Resumo
EP2842540A4 (en) MEDICAL CONNECTOR
EP2680775A4 (en) Cryogenic medical system
HRP20180870T1 (hr) Antitijelo-lijek konjugat
EP2810685A4 (en) CONNECTOR
PT2831109T (pt) Resumo
FR2998638B1 (fr) Raccord
EP2862861A4 (en) PIPERIDINYLPYRAZOLOPYRIDINDERIVAT
EP2852784A4 (en) PIPE CONNECTION
DOS2012000293S (es) Sarten
DE112013003377A5 (de) Hebelsystem
DOS2012000192S (es) Confiteria
EP2863921A4 (en) POLYMER-NSAID CONJUGATE
BR302012005880S1 (pt) Configuração aplicada em prótese
FI20115556L (fi) Kytkentäelin
DK3351554T3 (da) Glutenrelaterede forstyrrelser
LT2861118T (lt) Sanitarinis komplektas
EP2814560A4 (en) INTERCONNECTS
DE112013001038A5 (de) Kugel-Schaft-Verbindung
FR2995782B1 (fr) Sucres anti-pelliculaires
BR112013033305A2 (pt) ligação fusível